• Users Online: 209
  • Home
  • Print this page
  • Email this page
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Access statistics : Table of Contents
   2016| October-December  | Volume 5 | Issue 4  
    Online since February 14, 2017

 
 
  Archives   Previous Issue   Next Issue   Most popular articles   Most cited articles
 
Show all abstracts  Show selected abstracts  Export selected to
  Viewed PDF Cited
FULL LENGTH ARTICLE
Reactivation or reinfection in adult tuberculosis: Is that the question?*
Pere-Joan Cardona
October-December 2016, 5(4):400-407
DOI:10.1016/j.ijmyco.2016.09.017  
  2,745 304 7
REVIEW
Passive case finding for tuberculosis is not enough
Jennifer Ho, Greg J Fox, Ben J Marais
October-December 2016, 5(4):374-378
DOI:10.1016/j.ijmyco.2016.09.023  
  2,403 238 26
Diagnosing tuberculosis in the 21st century – Dawn of a genomics revolution?
Christopher Jeanes, Justin O'Grady
October-December 2016, 5(4):384-391
DOI:10.1016/j.ijmyco.2016.11.028  
  1,842 235 10
FULL LENGTH ARTICLE
In silico PASS analysis and determination of antimycobacterial, antifungal, and antioxidant efficacies of maslinic acid in an extract rich in pentacyclic triterpenoids
Prasad G Jamkhande, Shahbaz K Pathan, Shailesh J Wadher
October-December 2016, 5(4):417-425
DOI:10.1016/j.ijmyco.2016.06.020  
  1,631 174 22
REVIEW
Assuming the role of mitochondria inmycobacterial infection
Rikesh K Dubey
October-December 2016, 5(4):379-383
DOI:10.1016/j.ijmyco.2016.06.001  
  1,377 156 7
FULL LENGTH ARTICLE
Evaluation of different laboratory methods for rapid diagnosis of tuberculous pleurisy*
Safaa Amer, Azza El Hefnawy, Nashwa Abdel Wahab, Hadir Okasha, Amira Baz
October-December 2016, 5(4):437-445
DOI:10.1016/j.ijmyco.2016.07.001  
  1,381 137 7
Evaluation of the GenoType MTBDRplus assay for detection of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis isolates in central Ethiopia*
Zufan Bedewi Omer, Yalemtsehay Mekonnen, Adane Worku, Aboma Zewde, Girmay Medhin, Temesgen Mohammed, Rembert Pieper, Gobena Ameni
October-December 2016, 5(4):475-481
DOI:10.1016/j.ijmyco.2016.06.005  
  1,339 157 8
Rapid drug-susceptibility testing of Mycobacterium tuberculosis clinical isolates to first-line antitubercular drugs by nitrate reductase assay: A comparison with proportion method
Amrish Kohli, Gulnaz Bashir, Akeela Fatima, Abiroo Jan, Nayeem-u-din Wani, Junaid Ahmad
October-December 2016, 5(4):469-474
DOI:10.1016/j.ijmyco.2016.06.006  
  1,355 128 6
Extrapulmonary tuberculosis among females in South Asia—gap analysis
Jaishri Mehraj, Zain Yar Khan, Dania Khalid Saeed, Sadia Shakoor, Rumina Hasan
October-December 2016, 5(4):392-399
DOI:10.1016/j.ijmyco.2016.09.054  
  1,290 114 4
Inhibition of apoptosis by Rv2456c through nuclear factor-κB extends the survival of Mycobacterium tuberculosis
Kristen L. Jurcic Smith, Sunhee Lee
October-December 2016, 5(4):426-436
DOI:10.1016/j.ijmyco.2016.06.018  
  1,275 117 8
Mycobacterial contamination of bronchoscopes: Challenges and possible solutions in low resource settings
Dania Khalid Saeed, Sadia Shakoor, Seema Irfan, Rumina Hasan
October-December 2016, 5(4):408-411
DOI:10.1016/j.ijmyco.2016.08.002  
  1,243 135 4
Fluoroquinolone consumption and -resistance trends in Mycobacterium tuberculosis and other respiratory pathogens: Ecological antibiotic pressure and consequences in Pakistan, 2009–2015
S Shakoor, S Tahseen, K Jabeen, R Fatima, FR Malik, AH Rizvi, R Hasan
October-December 2016, 5(4):412-416
DOI:10.1016/j.ijmyco.2016.07.008  
  1,266 98 3
Antimycobacterial mechanism of vanillin involves disruption of cell-surface integrity, virulence attributes, and iron homeostasis
Sharda Sharma, Rahul Pal, Saif Hameed, Zeeshan Fatima
October-December 2016, 5(4):460-468
DOI:10.1016/j.ijmyco.2016.06.010  
  1,247 107 11
L-form transformation phenomenon in Mycobacterium tuberculosis associated with drug tolerance to ethambutol
Georgi Slavchev, Lilia Michailova, Nadya Markova
October-December 2016, 5(4):454-459
DOI:10.1016/j.ijmyco.2016.06.011  
  1,150 119 5
Efficacy and safety of quercetin and polyvinylpyrrolidone in treatment of patients with newly diagnosed destructive pulmonary tuberculosis in comparison with standard antimycobacterial therapy
Dmytro Butov, Svetlana Zaitseva, Tatyana Butova, Ganna Stepanenko, Olga Pogorelova, Natalia Zhelezniakova
October-December 2016, 5(4):446-453
DOI:10.1016/j.ijmyco.2016.06.012  
  1,126 105 3
Front-loaded sputum microscopy in the diagnosis of pulmonary tuberculosis
Nwachukwu O Ndubuisi, Onyeagba R Azuonye, Nwaugo O Victor, Okonkwo C Robert, Obiekwe Vivian
October-December 2016, 5(4):489-492
DOI:10.1016/j.ijmyco.2016.04.005  
  1,075 95 3
Risk assessment of hepatotoxicity among tuberculosis and human immunodeficiency virus/AIDS-coinfected patients under tuberculosis treatment
Williams Ngouleun, Prosper Cabral Biapa Nya, Anatole Constant Pieme, Phelix Bruno Telefo
October-December 2016, 5(4):482-488
DOI:10.1016/j.ijmyco.2016.05.003  
  980 119 3
EDITORIAL
Challenging dogma and stagnation in TB research
Matthew Bates
October-December 2016, 5(4):373-373
DOI:10.1016/S2212-5531(16)30251-5  
  898 101 -